当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析

君实生物-U

(688180)

  

流通市值:342.58亿  总市值:458.93亿
流通股本:7.66亿   总股本:10.27亿

君实生物-U(688180)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-4.66亿元,每股收益-0.42元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益639211.66万元,未分配利润-1075368.88万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1167558.81万元,负债528347.15万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,168,383,949.66500,591,459.941,948,317,315.721,271,200,009.95
营业总成本1,659,107,714.05782,539,195.353,215,859,236.062,261,152,311.32
其他经营收益
营业利润-475,011,078.54-281,715,865.28-1,338,824,837.02-969,121,005.27
利润总额-485,211,590.12-286,837,114.51-1,357,557,181.39-984,644,050.09
净利润-465,673,412.19-259,586,438.78-1,380,108,858.26-988,725,690.94
每股收益
其他综合收益-15,916,155.46-10,204,644.58-17,870,045.74-47,944,698.9
综合收益总额-481,589,567.65-269,791,083.36-1,397,978,904-1,036,670,389.84
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计4,784,755,600.844,255,015,311.224,283,817,107.054,585,525,675.86
非流动资产:
非流动资产合计6,890,832,474.916,642,054,455.586,498,143,303.056,272,087,848.84
资产总计11,675,588,075.7510,897,069,766.810,781,960,410.110,857,613,524.7
流动负债:
流动负债合计2,968,737,939.933,044,658,054.062,493,923,829.632,296,970,306.44
非流动负债:
非流动负债合计2,314,733,583.042,183,251,649.142,355,906,816.322,280,702,743.87
负债合计5,283,471,522.975,227,909,703.24,849,830,645.954,577,673,050.31
所有者权益(或股东权益):
归属于母公司股东权益合计6,372,334,459.95,620,244,628.635,860,424,336.296,172,509,756.39
股东权益合计6,392,116,552.785,669,160,063.65,932,129,764.156,279,940,474.39
负债和股东权益合计11,675,588,075.7510,897,069,766.810,781,960,410.110,857,613,524.7
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,404,458,148.66803,419,825.511,916,527,984.341,396,882,602.67
经营活动现金流出小计1,733,846,482827,751,022.013,350,369,193.882,510,354,687.28
经营活动产生的现金流量净额-329,388,333.34-24,331,196.5-1,433,841,209.54-1,113,472,084.61
投资活动产生的现金流量:
投资活动现金流入小计1,207,614,304.91490,394,088.861,957,267,588.79941,248,272
投资活动现金流出小计1,760,468,211.27832,019,803.482,850,049,722.352,024,759,021.67
投资活动产生的现金流量净额-552,853,906.36-341,625,714.62-892,782,133.56-1,083,510,749.67
筹资活动产生的现金流量:
筹资活动现金流入小计2,640,106,775.131,422,331,063.182,314,600,434.751,933,431,848.11
筹资活动现金流出小计1,255,742,433.161,035,553,067.931,291,454,659.771,033,401,651.88
筹资活动产生的现金流量净额1,384,364,341.97386,777,995.251,023,145,774.98900,030,196.23
汇率变动对现金及现金等价物的影响376,249.04-791,648.4312,014,641.06-6,855,136.19
现金及现金等价物净增加额502,498,351.3120,029,435.7-1,291,462,927.06-1,303,807,774.24
期末现金及现金等价物余额2,989,177,460.132,506,708,544.522,486,679,108.822,474,334,261.64
补充资料:
现金及现金等价物的净增加额502,498,351.31--1,291,462,927.06-
最新报告期:2025-08-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋周豫,戎晓婕-0.93-0.410.042025-08-30
方正证券许睿,周超泽-0.670.040.312025-08-26
方正证券许睿,周超泽-0.690.030.312025-06-19
TOP↑